These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 24880087

  • 1. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T, Yu JT, Zhu XC, Zhang QQ, Cao L, Wang HF, Tan MS, Gao Q, Qin H, Zhang YD, Tan L.
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [Abstract] [Full Text] [Related]

  • 2. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A, Pražienková V, Neprašová B, Kasperová BJ, Hrubá L, Holubová M, Zemenová J, Blum D, Železná B, Galas MC, Kuneš J, Maletínská L.
    J Alzheimers Dis; 2018 Oct; 62(4):1725-1736. PubMed ID: 29614684
    [Abstract] [Full Text] [Related]

  • 3. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
    Jiang T, Yu JT, Zhu XC, Tan MS, Wang HF, Cao L, Zhang QQ, Shi JQ, Gao L, Qin H, Zhang YD, Tan L.
    Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
    [Abstract] [Full Text] [Related]

  • 4. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X, Kosaraju J, Tam KY.
    Eur J Pharm Sci; 2017 Dec 15; 110():101-108. PubMed ID: 28359686
    [Abstract] [Full Text] [Related]

  • 5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL.
    J Neurosci; 2017 Mar 01; 37(9):2449-2462. PubMed ID: 28137967
    [Abstract] [Full Text] [Related]

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.
    Exp Neurol; 2008 Jul 01; 212(1):71-84. PubMed ID: 18490011
    [Abstract] [Full Text] [Related]

  • 7. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
    Chang JK, Leso A, Subaiea GM, Lahouel A, Masoud A, Mushtaq F, Deeb R, Eid A, Dash M, Bihaqi SW, Zawia NH.
    Curr Alzheimer Res; 2018 Jul 01; 15(7):655-663. PubMed ID: 29357795
    [Abstract] [Full Text] [Related]

  • 8. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T, Goñi-Oliver P, Lucas JJ, Avila J, Hernández F.
    J Neurochem; 2006 Dec 01; 99(6):1445-55. PubMed ID: 17059563
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.
    Ma XH, Duan WJ, Mo YS, Chen JL, Li S, Zhao W, Yang L, Mi SQ, Mao XL, Wang H, Wang Q.
    Brain Res; 2018 Jul 01; 1690():1-11. PubMed ID: 29596798
    [Abstract] [Full Text] [Related]

  • 10. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 01; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 11. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I.
    Neurobiol Dis; 2009 May 01; 34(2):381-8. PubMed ID: 19264130
    [Abstract] [Full Text] [Related]

  • 12. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A, Magrì A, Medina DX, Wisely EV, López-Aranda MF, Silva AJ, Oddo S.
    Aging Cell; 2013 Jun 01; 12(3):370-80. PubMed ID: 23425014
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
    Chou CH, Yang CR.
    Int J Mol Sci; 2021 May 19; 22(10):. PubMed ID: 34069531
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei JJ.
    J Neurochem; 2005 Mar 19; 92(5):1104-15. PubMed ID: 15715661
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
    Ozcelik S, Fraser G, Castets P, Schaeffer V, Skachokova Z, Breu K, Clavaguera F, Sinnreich M, Kappos L, Goedert M, Tolnay M, Winkler DT.
    PLoS One; 2013 Mar 19; 8(5):e62459. PubMed ID: 23667480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang H, Feng N, Wang L, Wang X.
    J Alzheimers Dis; 2012 Mar 19; 29(2):379-91. PubMed ID: 22233765
    [Abstract] [Full Text] [Related]

  • 19. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
    Jiang T, Tan L, Zhu XC, Zhou JS, Cao L, Tan MS, Wang HF, Chen Q, Zhang YD, Yu JT.
    Neurobiol Aging; 2015 Dec 19; 36(12):3176-3186. PubMed ID: 26364736
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice.
    Uno Y, Iwashita H, Tsukamoto T, Uchiyama N, Kawamoto T, Kori M, Nakanishi A.
    Brain Res; 2009 Nov 03; 1296():148-63. PubMed ID: 19698704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.